Pulling Back the Pre-Clinical Curtain
Are mouse models the best option we have?
William Aryitey |
The pre-clinical mouse model is an essential part of many translational medicine journeys, providing preliminary efficacy results that often determine if treatments are able to make the leap into clinical trials. With the growing availability of tools and techniques for genetic recombination, mouse models appear to allow access to increasingly relevant results... or do they? Some researchers argue that alternatives to animal models are overdue, others believe that they’re still the best pre-clinical option.
Can we gain more insight about the effectiveness of modern mouse models by ‘pulling back the curtain’ to see how these living pre-clinical pathways are created? Here, we speak with John Couse, portfolio director at Taconic Biosciences, to discuss how the shifting techniques and technologies in bioscience affect – and are affected by – mouse models.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!